Unveiling the Benefits of Vitamin D3 with SGLT-2 Inhibitors for Hypertensive Obese Obstructive Sleep Apnea Patients

Overview

Journal J Transl Med

Publisher Biomed Central

Specialties Biomedical Engineering
General Medicine

Date 2025 Mar 7

PMID 40055713

Authors

Huai Heng Loh

Siow Phing Tay

Ai Jiun Koa

Mei Ching Yong

Asri Said

Chee Shee Chai

Natasya Marliana Abdul Malik

Anselm Ting Su

Bonnie Bao Chee Tang

Florence Hui Sieng Tan

Norlela Sukor

Affiliations

Soon will be listed here.

Abstract

Background: Obstructive sleep apnea (OSA) is associated with poorer quality of life (QoL) and increased cardiovascular risks, which may be exacerbated by hypovitaminosis D. Sodium glucose transporter-2 inhibitor (SGLT2i) provides cardiovascular benefits beyond glycemic control. As vitamin D3 and SGLT2i act through different pathways with similar mechanisms in improving cardio-metabolic health, this study aimed to investigate the synergistic effects of this combination therapy in improving these parameters and QoL in hypertensive obese OSA patients.

Methods: Patients who fulfilled the study criteria were randomized to receive: (i) Dapagliflozin, (ii) vitamin D3, (iii) Dapagliflozin plus vitamin D3, or (iv) no treatment, for 16 weeks. The parameters evaluated included anthropometric measurements, uric acid, HbA1c, lipid profile, steatotic liver disease grade, plasma aldosterone concentration, plasma renin concentration, ultrasound flow-mediated dilatation of brachial artery, hsCRP, heart rate variability (HRV), Epworth Sleepiness Scale (ESS), and QoL scores.

Results: A total of 163 patients were recruited and 153 completed the study. The combination of vitamin D3 and Dapagliflozin treatment led to significant improvements in metabolic parameters and nocturnal heart rates, and prevented deterioration of HRV, with healthier HRV at the end of study visit compared to the control group. Only the combination group exhibited improvements in both ESS and QoL scores.

Conclusions: This is the first study to demonstrate beneficial effects of combining vitamin D3 and SGLT2i in cardio-metabolic outcomes and QoL in hypertensive obese OSA patients. These findings highlight the potential of this combination therapy in addressing the cardio-metabolic challenges and QoL in this patient population.

Trials Registration: NCT06690723. Registered 10 October 2024-Retrospectively registered, https://register.

Clinicaltrials: gov/prs/beta/studies/S000EWGF00000085/recordSummary.

References

Holick M, Binkley N, Bischoff-Ferrari H, Gordon C, Hanley D, Heaney R . Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(7):1911-30. DOI: 10.1210/jc.2011-0385. View

Mozos I, Marginean O . Links between Vitamin D Deficiency and Cardiovascular Diseases. Biomed Res Int. 2015; 2015:109275. PMC: 4427096. DOI: 10.1155/2015/109275. View

Gao M, Bhatia K, Kapoor A, Badimon J, Pinney S, Mancini D . SGLT2 Inhibitors, Functional Capacity, and Quality of Life in Patients With Heart Failure: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2024; 7(4):e245135. PMC: 11192183. DOI: 10.1001/jamanetworkopen.2024.5135. View

Md Isa Z, Mohd Nordin N, Mahmud M, Hashim S . An Update on Vitamin D Deficiency Status in Malaysia. Nutrients. 2022; 14(3). PMC: 8838715. DOI: 10.3390/nu14030567. View

Furukawa S, Miyake T, Senba H, Sakai T, Furukawa E, Yamamoto S . The effectiveness of dapagliflozin for sleep-disordered breathing among Japanese patients with obesity and type 2 diabetes mellitus. Endocr J. 2018; 65(9):953-961. DOI: 10.1507/endocrj.EJ17-0545. View

Mazidi M, Karimi E, Rezaie P, Vatanparast H . The impact of vitamin D supplement intake on vascular endothelial function; a systematic review and meta-analysis of randomized controlled trials. Food Nutr Res. 2017; 61(1):1273574. PMC: 5404423. DOI: 10.1080/16546628.2016.1273574. View

Mahboobifard F, Pourgholami M, Jorjani M, Dargahi L, Amiri M, Sadeghi S . Estrogen as a key regulator of energy homeostasis and metabolic health. Biomed Pharmacother. 2022; 156:113808. DOI: 10.1016/j.biopha.2022.113808. View

Ishii H, Nakajima H, Kamei N, Niiya T, Hiyoshi T, Hiramori Y . Quality-of-Life Comparison of Dapagliflozin Versus Dipeptidyl Peptidase 4 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (J-BOND Study). Diabetes Ther. 2020; 11(12):2959-2977. PMC: 7644655. DOI: 10.1007/s13300-020-00941-8. View

Cetin M, Kozdag G, Ural D, Kahraman G, Yilmaz I, Akay Y . Could decreased vitamin D levels be related with impaired cardiac autonomic functions in patients with chronic heart failure: an observational study. Anadolu Kardiyol Derg. 2014; 14(5):434-41. DOI: 10.5152/akd.2014.4869. View

10.

Radkhah N, Zarezadeh M, Jamilian P, Ostadrahimi A . The Effect of Vitamin D Supplementation on Lipid Profiles: an Umbrella Review of Meta-Analyses. Adv Nutr. 2023; 14(6):1479-1498. PMC: 10721514. DOI: 10.1016/j.advnut.2023.08.012. View

11.

Bjornsdottir E, Keenan B, Eysteinsdottir B, Arnardottir E, Janson C, Gislason T . Quality of life among untreated sleep apnea patients compared with the general population and changes after treatment with positive airway pressure. J Sleep Res. 2014; 24(3):328-38. PMC: 4439289. DOI: 10.1111/jsr.12262. View

12.

. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363(9403):157-63. DOI: 10.1016/S0140-6736(03)15268-3. View

13.

Iorga A, Cunningham C, Moazeni S, Ruffenach G, Umar S, Eghbali M . The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ. 2017; 8(1):33. PMC: 5655818. DOI: 10.1186/s13293-017-0152-8. View

14.

Bonora B, Avogaro A, Fadini G . Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence. Diabetes Metab Syndr Obes. 2020; 13:161-174. PMC: 6982447. DOI: 10.2147/DMSO.S233538. View

15.

Loh H, Sukor N . Obstructive sleep apnea and vitamin D level: Has the dust settled?. Clin Respir J. 2023; 18(3):e13593. PMC: 10928256. DOI: 10.1111/crj.13593. View

16.

Jensen N, Wehland M, Wise P, Grimm D . Latest Knowledge on the Role of Vitamin D in Hypertension. Int J Mol Sci. 2023; 24(5). PMC: 10003079. DOI: 10.3390/ijms24054679. View

17.

Wiviott S, Raz I, Bonaca M, Mosenzon O, Kato E, Cahn A . Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2018; 380(4):347-357. DOI: 10.1056/NEJMoa1812389. View

18.

Milder T, Stocker S, Day R, Greenfield J . Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease. Drug Saf. 2020; 43(12):1211-1221. PMC: 7582030. DOI: 10.1007/s40264-020-01010-6. View

18.

Lin I, Chen Y, Duong T, Nien S, Tseng I, Wu Y . Changes in Dietary Nutrient Intake and Estimated Glomerular Filtration Rate over a 5-Year Period in Renal Transplant Recipients. Nutrients. 2024; 16(1). PMC: 10780404. DOI: 10.3390/nu16010148. View

19.

Meng R, Radkhah N, Ghalichi F, Hamedi-Kalajahi F, Musazadeh V, Saleh S . The Impact of Vitamin D Supplementation on Improving Blood Pressure: Evidence Obtained From an Umbrella Meta-analysis. Clin Ther. 2023; 45(10):e208-e216. DOI: 10.1016/j.clinthera.2023.07.020. View